Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: Evidence from homologous versus heterologous binding analysis

被引:92
作者
Hastrup, H
Schwartz, TW
机构
[1] RIGSHOSP,MOL PHARMACOL LAB,DK-2100 COPENHAGEN,DENMARK
[2] UNIV COPENHAGEN,INST MOL BIOL,DEPT PROT CHEM,DK-2100 COPENHAGEN,DENMARK
关键词
substance P; neurokinin A; septide; 7TM receptor; neuropeptide; ligand binding;
D O I
10.1016/S0014-5793(96)01337-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The three main tachykinins, substance P, neurokinin A (NKA), and neurokinin B, are believed to be selective ligands for respectively the NK-1, NK-2 and NK-3 receptors, However, NKA also has actions which cannot be mediated through its normal NK-2 receptor and the synthetic peptide [pGlu(6),Pro(9)]-Substance P9-11- called septide - is known to have tachykinin-like actions despite its apparent lack of binding to any known tachykinin receptor, In the cloned NK-1 receptor expressed in COS-7 cells NKA and septide as expected were poor competitors for radiolabeled substance P. However, by using radiolabeled NKA and septide directly, it was found that both peptides in homologous binding assays as well as in competition against each other in fact bound to the NK-1 receptor with high affinity: K-d values of 0.51 +/- 0.15 nM (NKA) and 0.55 +/- 0.03 nM (septide), It is concluded that NKA and septide are high-affinity ligands for the NK-1 receptor but that they are poor competitors for substance P, which in contrast competes very well for binding with both NKA and septide.
引用
收藏
页码:264 / 266
页数:3
相关论文
共 21 条
[1]  
CASCIERI MA, 1992, MOL PHARMACOL, V41, P1096
[2]   THE EXTRACELLULAR DOMAIN OF THE NEUROKININ-1 RECEPTOR IS REQUIRED FOR HIGH-AFFINITY BINDING OF PEPTIDES [J].
FONG, TM ;
YU, H ;
HUANG, RRC ;
STRADER, CD .
BIOCHEMISTRY, 1992, 31 (47) :11806-11811
[3]  
GETHER U, 1993, J BIOL CHEM, V268, P7893
[4]   THE SEPTIDE-SENSITIVE TACHYKININ RECEPTOR - STILL AN ENIGMA [J].
GLOWINSKI, J .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (11) :365-367
[5]  
Hjorth SA, 1996, MOL PHARMACOL, V50, P977
[6]   INTERACTION OF SUBSTANCE-P WITH THE 2ND AND 7TH TRANSMEMBRANE DOMAINS OF THE NEUROKININ-1 RECEPTOR [J].
HUANG, RRC ;
YU, H ;
STRADER, CD ;
FONG, TM .
BIOCHEMISTRY, 1994, 33 (10) :3007-3013
[7]   IDENTIFICATION OF RESIDUES INVOLVED IN LIGAND-BINDING TO THE NEUROKININ-2 RECEPTOR [J].
HUANG, RRC ;
VICARIO, PP ;
STRADER, CD ;
FONG, TM .
BIOCHEMISTRY, 1995, 34 (31) :10048-10055
[8]   MULTIPLE TACHYKININ BINDING-SITES IN PERIPHERAL-TISSUES AND IN BRAIN [J].
LEE, CM ;
CAMPBELL, NJ ;
WILLIAMS, BJ ;
IVERSEN, LL .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 130 (03) :209-217
[9]   EVIDENCE FOR THE PRESENCE OF A SEPTIDE-SENSITIVE TACHYKININ RECEPTOR IN THE CIRCULAR MUSCLE OF THE GUINEA-PIG ILEUM [J].
MAGGI, CA ;
PATACCHINI, R ;
MEINI, S ;
GIULIANI, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (2-3) :309-311
[10]   CDNA CLONING OF BOVINE SUBSTANCE-K RECEPTOR THROUGH OOCYTE EXPRESSION SYSTEM [J].
MASU, Y ;
NAKAYAMA, K ;
TAMAKI, H ;
HARADA, Y ;
KUNO, M ;
NAKANISHI, S .
NATURE, 1987, 329 (6142) :836-838